For the drugs that seem to have higher efficacy or safety profiles in specific races, there are many existing factors such as the environment, dietary habits, and physiology.???It would be necessary to find what determines patient response to BiDil and to individualize treatment, noted Dr. David Goldstein, Wolfson Professor of Genetics at University College London, now the director of the Center